USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
28-Oct-2005
Global
Market Research
F404-01-00-00-00
HC01452-GL-MR_05946
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
Introduction
- Introduction
- Disclaimer
- Certification
- Contents
- Top 15 Growth Cancer Therapeutics
Market Overview
- Contents
- Research Scope and Methodology
- Abreviations
- Segmentation
- Targeted Therapy Segments
- Targeted Therapy Definitions
- Summary of Findings
- Market Drivers (1)
- Market Drivers (2)
- Challenges and Strategies (1)
- Challenges and Strategies (2)
- Challenges and Strategies (3)
- Challenges and Strategies (4)
- Challenges and Strategies (5)
Total Market Forecasts
- Contents
- Total Market Forecasts
- Total Market Forecasts by Therapeutic Class
- US Forecasts by Therapeutic Class
- Ex US Forecasts by Therapeutic Class
- Cytotoxic Therapy Forecasts
- Hormone Therapy Forecasts
- Targeted Therapy Forecasts
- Global Market Share Analysis
- US Market Share Analysis
- Ex US Market Share Analysis
NSCLC
- Contents
- Disease Overview
- Epidemiology Trends
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Breast Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Hormone Treatment Diagram
- Metastatic Treatment Diagram
- Revenue Forecasts
- Drug Development
Colorectal Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Prostate Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)
- Contents
- Top 15 Growth Therapeutic Cancer Drugs
- Rituxan/MabThera
- Taxotere
- Gleevec/Glivec
- Eloxatin
- Gemzar
- Herceptin
- Zometa
- Casodex
- Arimidex
- Avastin
- Camptosar/Campto
- Temodar/Temodal
- Xeloda
- Femara
- Erbitux
Recent Filings and Approvals
- Contents
- Recent Filings and Approvals
Key Late-Stage Pipeline Drugs
- Contents
- Key Late-Stage Pipeline Drugs
Awards
- Contents
- Frost & Sullivan Awards
- Company of the Year
- Product Innovation of the Year
- Product-Line/Pipeline Strategy of the Year
- Entrepreneurial Company of the Year
- Business Development Strategy of the Year
Frost & Sullivan Capabilities
- Contents
- Our Capabilities I
- Our Capabilities II
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
25 Sep 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Diagnostic Solutions, and Implantables
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantables.The issue features advanced medical devices such as peritoneal dialysis fluid system, cold sterilization-based au...
23 Sep 2026 | Global | Technology Research
Programmable Epigenome Editing for Disease Reversal
Programmable epigenome editing is developing as a distinct approach to controlling gene activity without changing the underlying DNA sequence. This report examines the landscape from the core editing technologies and delivery systems through the companies, academic programs and therapeutic applicati...
21 Sep 2026 | Europe | Market Research
HLTH Europe 2026: Five Key Takeaways and Growth Opportunities
HLTH Europe 2026, held in Amsterdam, brought together more than 5,000 stakeholders spanning providers, payers, health systems, technology vendors, start-ups, investors, and policymakers, providing a comprehensive view of the evolving European digital health landscape. Across conference sessions and ...
21 Sep 2026 | Global | Frost Radar
Frost Radar: Smart Nutraceuticals for Brain Health, 2026
This Frost Radar evaluates the evolving smart nutraceuticals landscape as consumer awareness of cognitive health, lifestyle-related stress, and healthy aging creates demand for scientifically validated, natural, and multifunctional brain health solutions. The market remains fragmented, with differen...
18 Sep 2026 | Global | Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F404-01-00-00-00 |
| Is Prebook | No |
Global Cancer Therapeutics Market Outlook
$4,950.00
Special Price $3,712.50 save 25 %